Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CHRO

Chromocell Therapeutics (CHRO)

Chromocell Therapeutics Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:CHRO
DateTimeSourceHeadlineSymbolCompany
3:00PMiHub NewswireFeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements
05/15/20244:15PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:CHROChromocell Therapeutics Corporation
05/15/20244:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CHROChromocell Therapeutics Corporation
05/13/20249:00AMGlobeNewswire Inc.Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024AMEX:CHROChromocell Therapeutics Corporation
04/09/20248:30AMGlobeNewswire Inc.Chromocell Issues Letter to Stockholders from Chief Executive OfficerAMEX:CHROChromocell Therapeutics Corporation
03/21/20248:30AMGlobeNewswire Inc.Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon ChandlerAMEX:CHROChromocell Therapeutics Corporation
03/18/202410:00AMGlobeNewswire Inc.Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023AMEX:CHROChromocell Therapeutics Corporation
03/11/20249:00AMGlobeNewswire Inc.Chromocell to Present at Sidoti Virtual Investor Conference March 13-14AMEX:CHROChromocell Therapeutics Corporation
02/27/20248:00AMGlobeNewswire Inc.Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare SolutionsAMEX:CHROChromocell Therapeutics Corporation
02/21/20244:47PMGlobeNewswire Inc.Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 MillionAMEX:CHROChromocell Therapeutics Corporation
 Showing the most relevant articles for your search:AMEX:CHRO